Likely active: portfolio news Jul 2025 Verified 5 Nov 2026
MGP Venture Fund III
Nashville early-stage venture firm with family office roots investing in life sciences, diagnostics, animal health, agtech and technology.
- Type
- VC firm
- Location
- Nashville, Tennessee, United States
- Stages
- Series A
- Backs
- Biotech and pharma, Medtech and digital health
- Sectors
- Healthtech and life sciences, Biotech, Agritech, Energy
- Fund size / AUM
- $150M MGP Venture Fund III (Form D offering, 2021); $140.3M gross private fund assets (Form ADV; private funds: 2, of which venture capital: 2)
- Portfolio mix
- Biotech and pharma 41%; Medtech and digital health 41%; B2B software 10%; Consumer products 3%; Climate and energy 3% (n=29)
- Website
- mtngp.com
Contacts on file
For MGP Venture Fund III, the paid file holds: 7 named decision-makers with roles; firm contact email (domain checked).
Get US Complete, $197 Free sample
One-time payment. No subscription. No account.
Notable investments
AN2 TherapeuticsCircular GenomicsMindera HealthPinkDx
Sources
- adviserinfo.sec.gov/firm/summary/318455
- mtngp.com/
- mtngp.com/portfolio/
- www.sec.gov/Archives/edgar/data/1895287/000189528721000002/
- mtngp.com/about/
- mtngp.com/focus/
Last checked 5 Nov 2026. Is something wrong? Tell us.
Appears in 25 lists
Series A agritech investors in the US (15)Venture capital firms in Nashville (24)Venture capital firms in Tennessee (33)Agritech venture capital firms in the US (55)Series A biotech investors in the US (59)Series A energy investors in the US (60)Series A agritech investors (65)Series A medtech investors in the US (76)Series A medtech investors (125)Agritech investors (137)Series A energy investors (139)Series A biotech investors (153)Series A healthtech investors in the US (164)Energy venture capital firms in the US (249)Biotech venture capital firms in the US (297)Medtech venture capital firms in the US (350)Series A investors in the US (372)Series A healthtech investors (401)Energy investors (421)Medtech investors (457)Biotech investors (484)Healthtech venture capital firms in the US (709)Series A investors (864)Healthtech investors (1,207)Venture capital firms in the US (2,975)